Skip to content

Comparison of Two Different Methods for Reducing Pain After Lung Surgery

Comparison of the Effectiveness of the Combination of Rhomboid Intercostal and Sub-serratus Plan Block and Rhomboid Intercostal Block for Postoperative Analgesis in Video-assisted Thoracopic Surgery (VATS)

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06260137
Enrollment
60
Registered
2024-02-15
Start date
2023-07-10
Completion date
2024-08-31
Last updated
2024-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Analgesia

Brief summary

The goal of this clinical study is to compare the effectiveness of the Rhomboid Intercostal Block and Sub-Servitus plan block and the effectiveness of the Rhomboid intercostal block in patients with video-supported thoracoscopic surgery. The main question it aims to answer is: Which of these two blocks more effectively reduces the patients' pain?

Interventions

Patients will be injected with a local anesthetic drug under the rhomboid intercostal muscle before surgery.

Patients will be injected with a local anesthetic drug under the rhomboid intercostal muscle and the serrates anterior muscle before surgery.

Sponsors

Uludag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients in American Society of Anesthesiologists (ASA) classes I, II and III for whom VATS is planned

Exclusion criteria

* Known or suspected local anesthetic allergy * coagulopathy * injection site infection * history of thoracic surgery * serious neurological or psychiatric disorder * severe cardiovascular disease * liver failure * renal failure

Design outcomes

Primary

MeasureTime frameDescription
Postoperative analgesiafirst 48 hours postoperativelyPatients' VAS scores and additional analgesic needs in the first 48 hours will be evaluated. VAS (visual pain scale) corresponds to a value between 0 and 10. A value of 0 means no pain, and a value of 10 is the most severe pain.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026